ENGLEWOOD, Colo., Aug. 12, 2021 /PRNewswire/ — Ampio Pharmaceuticals, Inc.
(NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment…

Click here to view the original article.